Director, Analytics Salary at Yahoo BETA

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting directly to the Sr. Director, Analytics and Insights, the Director, Forecasting role requires strategic thinking and expertise to provide critical contributions to brand strategy, launch and life-cycle planning and product and portfolio decisions. This role involves developing, refining, and communicating key revenue forecast assumptions as well as revenue forecast outputs to support decision-making across the

COMPANY OVERVIEW Lynx Analytics was founded in 2010 by a group of INSEAD students and professors with a strong research background in graph analytics. Several of our founders since then became professors and faculty directors of analytics centers at leading US universities. Our founding purpose? To apply graph theory to simplify and solve complex, real-world business problems. Our mission has evolved over the years, and we currently offer a range of cutting edge data analytics and AI solutions to help companies transform their operations and optimise their commercial performance. Back then, graph theory was mostly the purview of social networking sites. We wanted to expand this technology and help companies leverage their communities to unlock greater growth. Lynx has offices in Singapore, US, Hong Kong, Hungary, and operations in several other countries such as Canada, Germany, Indonesia. We work with some of the world’s largest companies and are constantly looking to expand our knowl

COMPANY OVERVIEW Lynx Analytics was founded in 2010 by a group of INSEAD students and professors with a strong research background in graph analytics. Several of our founders since then became professors and faculty directors of analytics centers at leading US universities. Our founding purpose? To apply graph theory to simplify and solve complex, real-world business problems. Our mission has evolved over the years, and we currently offer a range of cutting edge data analytics and AI solutions to help companies transform their operations and optimise their commercial performance. Back then, graph theory was mostly the purview of social networking sites. We wanted to expand this technology and help companies leverage their communities to unlock greater growth. Lynx has offices in Singapore, US, Hong Kong, Hungary, and operations in several other countries such as Canada, Germany, Indonesia. We work with some of the world’s largest companies and are constantly looking to expand our knowl

Director of Analytics Hybrid in San Francisco, CA Salary: $230,000 - $270,000 base + equity A rapidly growing startup is looking for a Director of Analytics to lead and expand a team of 15+ product and business analysts. This is a key strategic leadership role where you will shape the analytics function, provide actionable insights to drive business growth, and collaborate with cross-functional teams. The ideal candidate will have a strong business sense and proven experience working with consumer-facing online products. What You'll Do: Lead and Grow the Analytics Team: Manage a team of 15+ product and business analysts, with the opportunity to grow the team further by hiring senior-level analysts and managers. Mentor team members and foster a collaborative, results-driven environment. Strategic Decision-Making: Shape the analytics strategy and develop key metrics for business performance. Use data to provide insights that influence product decisions, customer experience improvements,

Job/Role Title: Director, CMC Analytics Reporting to: VP, CMC Location: San Francisco Bay Area About Us Ray Therapeutics' mission is to restore vision to people with retinal degenerations. RayTx is using a novel bioengineered optogenetic protein optimized for human vision delivered by AAV to restore visual function in a mutation agnostic approach and without the need for light enhancing eyewear. The company is developing its lead candidate RTx-015 in retinitis pigmentosa, a degenerative retinal disease with significant unmet medical need as well as a pipeline to treat both rare and large market indications. Ray Therapeutics is based in the San Francisco Bay Area. For additional information, please visit www.raytherapeutics.com. Position Summary We are currently seeking an exceptional leader as Director, CMC Analytics to join our team in the mission to restore vision to patients. The Director, CMC Analytics, will work closely with and report to our VP, CMC in all aspects of outsourced e

We are partnered with an innovative and growing immune-oncology biotech based out of South San Francisco that is seeking a talented and proven Director of Analytical Development and Quality Control to lead efforts on their mAb products, overseeing outsourced testing across the entire portfolio. This is a great opportunity for an analytical leader who will have impact on programs from preclinical through late stage.Responsibilities:Oversee relationships with CDMOs/CTLs/CROs, ensuring GMP compliance and quality standardsGuide development and validation of analytical testing strategies, ensuring reliability and regulatory alignmentLead outsourced quality control functions, ensuring appropriate testing methods and regulatory compliance for monoclonal antibodiesEnsure compliance with GMP standards and regulatory guidelines across outsourced manufacturing, testing, and analytical activitiesCollaborate with internal teams to align product development, manage risks, and ensure timely regulator

About Aerogen Pharma Aerogen Pharma is a US based clinical-stage specialty pharmaceutical company with a mission to develop inhaled drug/biologic and device combination that will transform the standard of care for acute and critically ill patients. Our goal is to create medically superior, proprietary and commercially differentiated combination products by combining proven therapeutic molecules with a unique, high-performance aerosol delivery system. We are embarking on an exciting and dynamic stage in our combination product development, moving into phase 3 clinical trial for one of the biggest breakthroughs in Neonatal care. We are a team of passionate industry experts who are leading, shaping, and driving a potentially transformative medical breakthrough for the treatment of neonatal respiratory distress syndrome (RDS) in the developed world. Additionally, in partnership with The Bill & Melinda Gates Foundation, we have an ambitious program in development to bring low-cost surfactan

Join one of Fortune’s 100 Best Companies to Work For as an AML Investigator specializing in Canadian STR filings. We’re looking for a seasoned professional with hands-on experience managing the full lifecycle of Suspicious Transaction Reports (STRs) in Canada — including submission to FINTRAC. This is not a typical alert review role; deep knowledge of Canadian AML regulations is a must. You’ll be working directly with a senior AML leader as their go-to person for Canadian AML investigations. This is a high-impact, fully remote contract role with strong potential for long-term growth. Job Descirption: Hyperfocus on FINTRAC AML reviews and STR Filings. AML Transaction Monitoring Alert Queue Management. Identifying gaps in the design and operating effectiveness of AML and STR control frameworks. Leading efforts with internal teams to remediate any activities for continuous process improvement, including managing projects for AML and STR compliance enhancement. Helping to partner with our